ReviewTranslational andrology and urology2025
Management of vesicourethral anastomotic stenosis.
Review in Translational andrology and urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vesicourethral anastomotic stenosis (VUAS) is a complication of radical prostatectomy characterized by fibrotic narrowing at the surgical connection of bladder and urethra. It is distinct from bladder neck contractures (BNC) as BNC occur with prostate in situ and VUAS occurs after a surgical anastomosis is created after removal of the prostate. Clinically, VUAS may present with obstructive lower urinary tract symptoms, fistula, urine leak, or paradoxically improving continence due to the narrowing of the vesicoureteral junction. There are multiple risk factors for VUAS from preoperative, intraoperative, and postoperative considerations. These include comorbidities and technical considerations as well as necessary adjuvant treatments. Diagnostics including imaging and cystoscopy are crucial to the identification of VUAS. Management focuses on restoration of stable, unobstructed urinary flow while minimizing treatment-related stress urinary incontinence. Endoscopic techniques remain the firstline treatments for non-obliterated VUAS, while refractory or complex cases may require formal bladder neck reconstruction. Urinary diversion, via ileal conduit or Indiana pouch, is a last resort for the most severe VUAS. For patients with VUAS that are not surgical candidates, catheterization via clean intermittent catheterization (CIC) or suprapubic tube (SPT) remains a viable option. VUAS remains a challenging condition with a wide spectrum of therapeutic options. Selection of intervention must be tailored to the severity of the stenosis, presence of complicating factors, and patient goals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.